Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Medtronic plcNYSE: MDT

Gross Margin · Q1 FY2027 · quarter ended Jul 2026

Gross margin widens to 65.0%

Gross margin was 65.0% in Q1 FY2027, up 7.3 pp from a year earlier. On a trailing-twelve-month basis it was 66.7%, up 3.3 pp year over year. Over 3 fiscal years it narrowed by 0.7 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2026 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
65.0%-11.8 pp QoQ
Last fiscal yearApr 2026
65.0%-0.3 pp YoY
LTMJul 2026
66.7%+3.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.3 pp——
1 year-0.3 pp——
3 years-0.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
65.0%
Year-over-year change
-0.3pp

Gross Margin vs competitors

How MDT compares with its peers on the latest reported figures

  • MDT's LTM Jul 2026 gross margin of 66.7% is the 6th highest of the 9 companies compared; the peer median is 67.9%.
  • Its year-over-year change of +3.3 pp is the 2nd highest of 9, against a peer median of +0.4 pp.
  • Over three fiscal years its change of -0.7 pp compares with a peer median of +1.9 pp.
MDT Competitors Peer median
Gross Margin for MDT and competitors
Company Period LTM level YoY 3-year change
EWEdwards Lifesciences CorporationLTM Jun 202678.0% -0.9 pp-0.2 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202669.9% -1.2 pp-9.3 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
PHGKoninklijke Philips N.V.LTM Jun 202645.9% +2.1 pp+4.8 pp
AVRAnteris Technologies Global Corp.LTM Mar 202628.3% -24.8 pp-25.9 pp
Peer median (excluding MDT) 67.9%+0.4 pp+1.9 pp

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Revenue31.69B31.23B32.36B33.54B36.36B
Cost of Revenue10.15B10.72B11.22B11.63B12.72B
Gross Profit21.54B20.51B21.15B21.91B23.64B
Gross Margin68.0%65.7%65.3%65.3%65.0%
Research & Development2.75B2.7B2.74B2.73B2.87B
Selling, General & Admin10.29B10.42B10.74B10.85B11.78B
Operating Expenses15.79B15.02B16B15.95B17.18B
Depreciation & Amortization2.71B2.7B2.65B2.86B2.96B
EBITDA8.78B8.7B8.2B9.22B9.81B
EBITDA Margin27.7%27.9%25.3%27.5%27.0%
Operating Income5.75B5.49B5.14B5.96B6.47B
Operating Margin18.2%17.6%15.9%17.8%17.8%
Interest Income00000
Interest Expense553M636M719M729M715M
Other Income / Expenses(235M)(121M)(307M)(327M)(331M)
Income Before Tax5.52B5.36B4.84B5.63B6.14B
Pre-Tax Margin17.4%17.2%14.9%16.8%16.9%
Income Tax Expense456M1.58B1.13B936M1.3B
Net Income5.04B3.76B3.68B4.66B4.8B
Net Margin15.9%12.0%11.4%13.9%13.2%
EPS (Basic)3.752.832.773.633.75
EPS (Diluted)3.732.822.763.613.73
Weighted Avg Shares1.34B1.33B1.33B1.29B1.28B
Weighted Avg Shares (Diluted)1.35B1.33B1.33B1.29B1.29B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.